Back to funds
View filing
Defilade Capital Management, L.P.
hedge fundUpdated 27 days agoManaged by Defilade Capital Management, L.P. • Latest filing Q2 2026
Portfolio value
$746.9M
Q2 2026
Filings
3
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 3 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $737.7M |
| Q1 2026 | $712.2M |
| Q2 2026 | $746.9M |
Top holdings
39 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | L LLY ELI LILLY & CO | $46.9M | 39.1K | 6.28% | — |
| 2 | P PFE PFIZER INC | $42.7M | 1.77M | 5.71% | — |
| 3 | V VEEV VEEVA SYS INC | $42M | 236.7K | 5.62% | — |
| 4 | B BMRN BIOMARIN PHARMACEUTICAL INC | $39M | 682.0K | 5.22% | — |
| 5 | ? N/A PTC THERAPEUTICS INC | $35.4M | 433.7K | 4.74% | — |
| 6 | B BAX BAXTER INTL INC | $31.1M | 1.46M | 4.17% | — |
| 7 | I INSM INSMED INC | $30M | 281.8K | 4.02% | — |
| 8 | Z ZBH ZIMMER BIOMET HOLDINGS INC | $27.3M | 317.4K | 3.66% | — |
| 9 | P PODD INSULET CORP | $26.9M | 176.9K | 3.61% | — |
| 10 | T TMO THERMO FISHER SCIENTIFIC INC | $26M | 51.9K | 3.49% | — |
| 11 | A ABT ABBOTT LABORATORIES | $25.9M | 285.8K | 3.47% | — |
| 12 | A ASND ASCENDIS PHARMA A/S | $25.3M | 94.8K | 3.39% | — |
| 13 | S SOLV SOLVENTUM CORP | $24.4M | 316.5K | 3.27% | — |
| 14 | M MDT MEDTRONIC PLC | $23.7M | 303.3K | 3.18% | — |
| 15 | E ELAN ELANCO ANIMAL HEALTH INC | $21.3M | 864.1K | 2.85% | — |
| 16 | M MGRB AGIOS PHARMACEUTICALS INC | $20.3M | 546.8K | 2.72% | — |
| 17 | N NVST ENVISTA HOLDINGS CORPORATION | $19.1M | 726.1K | 2.56% | — |
| 18 | R RVMDW REVOLUTION MEDICINES INC | $15.5M | 82.8K | 2.08% | — |
| 19 | I ICUI ICU MED INC | $15.5M | 105.7K | 2.07% | — |
| 20 | C COGT COGENT BIOSCIENCES INC | $15.2M | 393.4K | 2.04% | — |